The effect of erlotinib on EGFR and downstream signaling in oral cavity squamous cell carcinoma

PURPOSE: To determine if there are differences in biomarker modulation and EGFR degradation between tumor and the normal mucosa following treatment with an EGFR inhibitor, erlotinib, in head and neck cancer. METHODS: Patients with primary oral cavity squamous cell cancers received a course of erloti...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Head Neck
Hoofdauteurs: Tsien, Christina I., Nyati, Mukesh K., Ahsan, Aarif, Ramanand, Susmita G, Chepeha, Douglas B., Worden, Francis P., Helman, Joseph I., D’Silva, Nisha, Bradford, Carol R., Wolf, Gregory T., Lawrence, Theodore S., Eisbruch, Avraham
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4364542/
https://ncbi.nlm.nih.gov/pubmed/22907806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hed.23128
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items